Biological evaluation of [4‐(4‐aminophenyl)‐1‐(4‐fluorophenyl)‐1 H ‐pyrrol‐3‐yl](3,4,5‐trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models
Archiv der Pharmazie · 2023
DOI: 10.1002/ardp.202300354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2023. Verfasst von Carmela Mazzoccoli und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This work was supported by the Italian Ministry of Health (IT-MOH) through funding of Ricerca Corrente 2022-2023, Ministero della Salute.
Abstract (Originalsprache)
Targeting tubulin polymerization and depolymerization represents a promising approach to treat solid tumors. In this study, we investigated the molecular mechanisms underlying the anticancer effects of a structurally novel tubulin inhibitor, [4‐(4‐aminophenyl)‐1‐(4‐fluorophenyl)‐1 H ‐pyrrol‐3‐yl](3,4,5‐trimethoxyphenyl)methanone (ARDAP), in two‐ and three‐dimensional MCF‐7 breast cancer models. At sub‐cytotoxic concentrations, ARDAP showed a marked decrease in cell proliferation, colony formation, and ATP intracellular content in MCF‐7 cells, by acting through a cytostatic mechanism. Additionally, drug exposure caused blockage of the epithelial‐to‐mesenchymal transition (EMT). In 3D cell culture, ARDAP negatively affected tumor spheroid growth, with inhibition of spheroid formation and reduction of ATP concentration levels. Notably, ARDAP exposure promoted the differentiation of MCF‐7 cells by inducing: (i) expression decrease of Oct4 and Sox2 stemness markers, both in 2D and 3D models, and (ii) downregulation of the stem cell surface marker CD133 in 2D cell cultures. Interestingly, treated MCF7 cells displayed a major sensitivity to cytotoxic effects of the conventional chemotherapeutic drug doxorubicin. In addition, although exhibiting growth inhibitory effects against breast cancer cells, ARDAP showed insignificant harm to MCF10A healthy cells. Collectively, our results highlight the potential of ARDAP to emerge as a new chemotherapeutic agent or adjuvant compound in chemotherapeutic treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, Italy.
- Clinical Pathology Unit, A.O.R. San Carlo Potenza, Potenza, Italy.
- Clinical Pathology Unit, Azienda Sanitaria Locale, Potenza, Italy.
- Hospital Pharmacy, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, Italy.
- Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Eco-Sustainable Marine Biotechnology, Stazione Zoologica Anton Dohrn, Naples, Italy.
Förderung
- This work was supported by the Italian Ministry of Health (IT-MOH) through funding of Ricerca Corrente 2022-2023
- Ministero della Salute
Zitieren
APA
Mazzoccoli, C., Crispo, F., Laurenzana, I., Pietrafesa, M., Sisinni, L., Lerose, R., Telesca, D., Milella, M. R., Liu, T., Della Sala, G., Sebastiani, J., Silvestri, R., & La Regina, G. (2023). Biological evaluation of [4‐(4‐aminophenyl)‐1‐(4‐fluorophenyl)‐1 H ‐pyrrol‐3‐yl](3,4,5‐trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300354
Vancouver
Mazzoccoli C, Crispo F, Laurenzana I, Pietrafesa M, Sisinni L, Lerose R, et al. Biological evaluation of [4‐(4‐aminophenyl)‐1‐(4‐fluorophenyl)‐1 H ‐pyrrol‐3‐yl](3,4,5‐trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models. Archiv der Pharmazie. 2023. doi:10.1002/ardp.202300354
BibTeX
@article{Mazzoccoli2023,
author = {Mazzoccoli, Carmela and Crispo, Fabiana and Laurenzana, Ilaria and Pietrafesa, Michele and Sisinni, Lorenza and Lerose, Rosa and Telesca, Donatella and Milella, Maria R and Liu, Te and Della Sala, Gerardo and Sebastiani, Jessica and Silvestri, Romano and La Regina, Giuseppe},
title = {Biological evaluation of [4‐(4‐aminophenyl)‐1‐(4‐fluorophenyl)‐1 H ‐pyrrol‐3‐yl](3,4,5‐trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models},
journal = {Archiv der Pharmazie},
year = {2023},
doi = {10.1002/ardp.202300354}
}
EUVIMED